Page 25 - Hikma - Oncology booklet
P. 25
Indication
Click to edit Master title style
Breast Cancer (BC)
Non-Small Cell Lung Cancer (NSCLC)
Hormone Refractory Prostate Cancer (HRPC)
Gastric Adenocarcinoma (GC)
Squamous Cell Carcinoma of the Head and
Neck Cancer (SCCHN)
Dosage
Breast Cancer :
locally advanced 60 - 100 Single agent
or metastatic mg/m 2
Breast Cancer adjuvant :
Administered 1 hour after adricin
2
75 50 mg/m and cyclophosphamide
mg/m 2 500 mg/m every 3 weeks for 6
2
cycles.
18/01/2020 1
24
